Boston Scientific's FARAPULSE Pulsed Field Ablation System for paroxysmal atrial fibrillation receives approval in Japan.
Boston Scientific has received approval from Japan’s Pharmaceuticals and Medical Devices Agency for its FARAPULSE Pulsed Field Ablation System, designed to treat paroxysmal atrial fibrillation (AF) by isolating pulmonary veins. This innovative system uses non-thermal electrical fields instead of heat, enhancing safety and efficacy. With over 125,000 patients studied globally, the device will launch in Japan soon, pending reimbursement approval.
September 27, 2024
9 Articles